A newly established anti-interleukin-2 receptor β chain (p75) monoclonal antibody inhibits the induction of allo-specific cytotoxic lymphocytes in combination with anti-interleukin-2 receptor α chain (p55) monoclonal antibody

Anti-ganglioside GM[2] monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes

Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor αβ antibody